Back
Ganfeng Lithium Group Co., Ltd. Vs. Forte Biosciences, Inc. Industry Stock Comparison
Buy
58
GNENF
Ganfeng Lithium Group Co., Ltd.
Last Price:
$9.19
Seasonality Move:
6.48%
Sell
43
FBRX
Forte Biosciences, Inc.
Last Price:
$25.56
Seasonality Move:
1.35%
Buy
58
Ganfeng Lithium Group Co., Ltd. (GNENF)
is a Buy
Is Ganfeng Lithium Group Co., Ltd. a Buy, Sell or Hold?
-
The current Ganfeng Lithium Group Co., Ltd. [GNENF] share price is $9.19. The Score for GNENF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
GNENF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Forte Biosciences, Inc. (FBRX)
is a Sell
Is Forte Biosciences, Inc. a Buy, Sell or Hold?
-
The current Forte Biosciences, Inc. [FBRX] share price is $25.58. The Score for FBRX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
FBRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GNENF Stock Price Chart
What is Ganfeng Lithium Group Co., Ltd.'s stock price today?
-
The Ganfeng Lithium Group Co., Ltd. share price today is $9.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GNENF is experiencing buying pressure, which is a positive indicator for future bullish movement.
FBRX Stock Price Chart
What is Forte Biosciences, Inc.'s stock price today?
-
The Forte Biosciences, Inc. share price today is $25.58Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GNENF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 61.93 | Buy |
| Chaikin Money Flow: | 3272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.36 - 8.78) | Buy |
| Bollinger Bands (100): | (6.66 - 8.38) | Buy |
FBRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.88 | Sell |
| Relative Strength Index (14 RSI): | 44.46 | Sell |
| Chaikin Money Flow: | 203132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.06 - 29.28) | Sell |
| Bollinger Bands (100): | (20.38 - 31.14) | Sell |
GNENF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.85 | Buy |
| 20-day SMA: | 8.13 | Buy |
| 50-day SMA: | 8.07 | Buy |
| 200-day SMA: | 5.94 | Buy |
| 8-day EMA: | 8.69 | Buy |
| 20-day EMA: | 6.79 | Buy |
| 50-day EMA: | 3.94 | Buy |
| 200-day EMA: | 1.22 | Buy |
FBRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.91 | Sell |
| 20-day SMA: | 26.3 | Sell |
| 50-day SMA: | 28.83 | Sell |
| 200-day SMA: | 18.9 | Buy |
| 8-day EMA: | 25.73 | Sell |
| 20-day EMA: | 26.48 | Sell |
| 50-day EMA: | 27.11 | Sell |
| 200-day EMA: | 21.11 | Buy |
Ganfeng Lithium Group Co., Ltd. Earnings Growth & GNENF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Forte Biosciences, Inc. Earnings Growth & FBRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.32 per share, a decrease this year of $0.09 per share, and an increase next year of $0.19 per share.
Ganfeng Lithium Group Co., Ltd. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Forte Biosciences, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||